000 01513 a2200409 4500
005 20250518061911.0
264 0 _c20200203
008 202002s 0 0 eng d
022 _a2050-084X
024 7 _a10.7554/eLife.48648
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSkorput, Alexander Gj
245 0 0 _aThe NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero.
_h[electronic resource]
260 _beLife
_c09 2019
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAlcohol Drinking
_xadverse effects
650 0 4 _aAnimals
650 0 4 _aBumetanide
_xadministration & dosage
650 0 4 _aCerebral Cortex
_xdrug effects
650 0 4 _aDisease Models, Animal
650 0 4 _aFemale
650 0 4 _aFetal Alcohol Spectrum Disorders
_xphysiopathology
650 0 4 _aGABAergic Neurons
_xdrug effects
650 0 4 _aMice
650 0 4 _aPrefrontal Cortex
_xdrug effects
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications
_xphysiopathology
650 0 4 _aSodium Potassium Chloride Symporter Inhibitors
_xadministration & dosage
650 0 4 _aSolute Carrier Family 12, Member 2
_xmetabolism
650 0 4 _aTreatment Outcome
650 0 4 _agamma-Aminobutyric Acid
_xmetabolism
700 1 _aLee, Stephanie M
700 1 _aYeh, Pamela Wl
700 1 _aYeh, Hermes H
773 0 _teLife
_gvol. 8
856 4 0 _uhttps://doi.org/10.7554/eLife.48648
_zAvailable from publisher's website
999 _c30135606
_d30135606